Sandoz Executive and Leadership Team

Martin Fournier, the Vice President, Finance & Chief Financial Officer at Sandoz, directs all global financial planning and capital allocation strategies. Overseeing the fiscal health of the organization, the Vice President, Finance & Chief Financial Officer ensures robust investment in the development of generic medicines and biosimilars. This leadership role involves managing complex budgetary requirements across international markets to support long-term growth objectives. By optimizing cost structures and enhancing operational efficiency, Martin Fournier directly impacts the ability of the company to provide affordable treatments to patients worldwide. The Chief Financial Officer collaborates with the board to maintain transparency and drive sustainable value creation. Through rigorous financial oversight, Fournier secures the resources necessary for the continued expansion of the pharmaceutical portfolio, ensuring that the company remains a leader in the global healthcare sector while navigating diverse economic landscapes.

Keren Haruvi, the President, Sandoz (North America) at Sandoz, manages all commercial operations and market expansion initiatives across the North American region. Overseeing the distribution of oncology and immunology treatments, the President, Sandoz (North America) ensures that healthcare providers receive consistent access to essential generic medicines. This leadership role involves navigating complex regulatory environments and building strategic partnerships with regional health systems to improve patient outcomes. By driving market penetration and optimizing supply chain logistics, Keren Haruvi directly impacts the competitive positioning of the company within the North American pharmaceutical landscape. The President, Sandoz (North America) coordinates with global leadership to align regional goals with the overarching mission of increasing medicine accessibility. Through proactive engagement with stakeholders, Haruvi strengthens the presence of the company in the region, fostering growth and ensuring the delivery of high-quality therapeutic solutions to diverse patient populations.

Biakmawi Phaipi, the Team Captain at Sandoz, directs internal collaborative efforts and cross-functional project execution. Overseeing the alignment of departmental goals, the Team Captain ensures that internal teams maintain focus on the development and manufacturing of high-quality biosimilars. This leadership role involves facilitating communication between research units and operational departments to streamline workflows and enhance productivity. By fostering a culture of accountability and innovation, Biakmawi Phaipi directly impacts the efficiency of the internal processes that support the global delivery of medicines. The Team Captain coordinates with other executive leaders to resolve operational bottlenecks and ensure that project timelines remain consistent with corporate objectives. Through consistent guidance and team development, Phaipi drives the collective performance of the organization, ensuring that every internal function contributes effectively to the broader mission of providing affordable healthcare solutions to patients across multiple therapeutic areas.

Elena Morchenko, the Med at Sandoz, directs clinical strategy and medical affairs to ensure the safety and efficacy of the generic medicine portfolio. Overseeing the integration of scientific data into product development, the Med ensures that all treatments meet rigorous quality standards for oncology and cardiovascular health. This leadership role involves managing clinical evaluations and providing medical expertise to support the regulatory approval of new biosimilars. By bridging the gap between scientific research and commercial application, Elena Morchenko directly impacts the clinical credibility and market success of the company. The Med collaborates with global health authorities to maintain compliance and advance the therapeutic impact of the product line. Through meticulous oversight of medical protocols, Morchenko ensures that the company continues to provide reliable, high-quality healthcare solutions, ultimately improving patient outcomes and reinforcing the reputation of the organization as a trusted provider of essential medicines.